Cost analysis for ambulatory treatment of cystic fibrosis patients in Germany. Overview of the prospective study results;Evaluation von Kosten der ambulanten Behandlung bei Mukoviszidose in Deutschland : Übersicht über die Ergebnisse einer prospektiven Studie
Ambulatory care; Cost analysis; Cystic fibrosis; Medication; Quality of life
Indexed keywords
ANTIBIOTIC AGENT;
ENZYME;
VITAMIN;
ADOLESCENT;
ADULT;
AMBULATORY CARE;
CHILD;
CLINICAL ASSESSMENT;
CLINICAL EVALUATION;
CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
CYSTIC FIBROSIS;
DEMOGRAPHY;
DRUG COST;
FINANCIAL MANAGEMENT;
GERMANY;
GROUPS BY AGE;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HEPATOBILIARY DISEASE;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OUTPATIENT CARE;
OXYGEN THERAPY;
PANCREAS INSUFFICIENCY;
PRESCHOOL CHILD;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
REIMBURSEMENT;
REVIEW;
SCHOOL CHILD;
ARTICLE;
COST;
ECONOMICS;
FEMALE;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
INSURANCE;
MALE;
PATIENT ATTITUDE;
PATIENT CARE;
PSYCHOLOGICAL ASPECT;
PUBLIC HEALTH;
STATISTICS;
ADOLESCENT;
AMBULATORY CARE;
CHILD;
CHILD, PRESCHOOL;
COSTS AND COST ANALYSIS;
CYSTIC FIBROSIS;
DELIVERY OF HEALTH CARE;
DRUG COSTS;
FEMALE;
FINANCING, PERSONAL;
GERMANY;
HEALTH RESOURCES;
HUMANS;
INFANT;
INSURANCE COVERAGE;
MALE;
NATIONAL HEALTH PROGRAMS;
PATIENT CARE TEAM;
QUALITY ASSURANCE, HEALTH CARE;
QUALITY OF LIFE;
REIMBURSEMENT MECHANISMS;
SICK ROLE;
YOUNG ADULT;
Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin
Stern M, Sens B, Wiedemann B, et al., Hrsg. Qualitä tssicherungMukoviszidose - Überblick über den Gesundheitszustand der Patienten inDeutschland 2005. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft,2007.
The revised German Cystic Fibrosis Questionnaire: Validation of adisease-specific health-related quality of life instrument
K. Wenninger P. Aussage U. Wahn 2003 The revised German Cystic FibrosisQuestionnaire: validation of a disease-specific health-related quality of lifeinstrument Qual Life Res 12 77 85
Cystic fibrosis - Cost of illness and considerations for the economicevaluation of potential therapies
C. Krauth N. Jalilvand T. Welte 2003 Cystic fibrosis - cost of illnessand considerations for the economic evaluation of potential therapiesPharmacoeconomics 14 1001 24
Expenditures for care of children with chronic illnesses enrolled inWashington State Medicaid Program, fiscal year 1993
H. Ireys G. Anderson T. Shaffer 1997 Expenditures for care of childrenwith chronic illnesses enrolled in Washington State Medicaid Program, fiscalyear 1993 Pediatrics 100 197 204
Cost of care for individuals with cystic fibrosis: A regression approachto determining the impact of recombinant human DNase
J.A. Johnson M.A. Connolly P. Jacobs 1999 Cost of care for individualswith cystic fibrosis: a regression approach to determining the impact ofrecombinant human DNase Pharmacotherapy 19 1159 66
A cost description of an adult cystic fibrosis unit and cost analyses ofdifferent categories of patients
M. Robson J. Abbott K. Webb 1992 A cost description of an adult cysticfibrosis unit and cost analyses of different categories of patients Thorax 47684 9
The nonhospital costs of care of patients with CF in the Netherlands:Results of a questionnaire
M.F. Wildhagen J.B. Verheij J.G. Verzijl 1996 The nonhospital costs ofcare of patients with CF in the Netherlands: results of a questionnaire EurRespir J 9 2215 9
